Literature DB >> 10024578

Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes.

R E Molestina1, R D Miller, J A Ramirez, J T Summersgill.   

Abstract

We have previously shown that different isolates of Chlamydia pneumoniae display heterogeneity in the in vitro stimulation of chemokines and adhesion molecules from infected human endothelial cells. In the present study, we examined the ability of different isolates of C. pneumoniae to promote transendothelial migration of neutrophils and monocytes. Human umbilical vein endothelial cells (HUVEC) were infected with low (<15)-passage C. pneumoniae isolates A-03, PS-32, and BR-393 and high (>40)-passage isolates BAL-16, TW-183, and T-2634, and levels of neutrophil and monocyte transendothelial migration were determined following 24 h of infection. Compared to mock-infected controls, significant increases in neutrophil migration were observed in response to most C. pneumoniae isolates examined (P < 0.001). Levels of monocyte migration were significantly increased in response to TW-183 and T-2634 (P < 0.001). Serial passage (>40 times) of the three low-passage isolates in HEp-2 cell cultures prior to infection of HUVEC generally resulted in the promotion of higher levels of neutrophil and monocyte transendothelial migration. These findings were compatible with differences observed in the extent of interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) stimulation between low- and high-passage A-03, PS-32, and BR-393. As opposed to C. pneumoniae, infection with C. trachomatis L2 caused only a slight increase in neutrophil transendothelial migration, which correlated with the lack of measurable IL-8 levels by this species. However, significant levels of monocyte migration were induced in response to C. trachomatis L2 despite a lack of measurable MCP-1 stimulation. C. trachomatis serovars A and E also failed to induce IL-8 and MCP-1 production in HUVEC. Results from this study indicate that the passage history of C. pneumoniae may play a role in the divergence of stimulatory activities observed among isolates in human endothelial cells. In addition, the differences observed between this organism and C. trachomatis suggest that the upregulation of IL-8 and MCP-1 in endothelial cells may be unique to C. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024578      PMCID: PMC96464     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  The pathogenesis of atherosclerosis: an overview.

Authors:  C J Schwartz; A J Valente; E A Sprague; J L Kelley; R M Nerem
Journal:  Clin Cardiol       Date:  1991-02       Impact factor: 2.882

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

4.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

5.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

Authors:  C Haslett; L A Guthrie; M M Kopaniak; R B Johnston; P M Henson
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

6.  Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.

Authors:  K Laitinen; A Laurila; L Pyhälä; M Leinonen; P Saikku
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Monocyte chemoattractant protein-1 in human atheromatous plaques.

Authors:  N A Nelken; S R Coughlin; D Gordon; J N Wilcox
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

8.  A comparison of substrates for human umbilical vein endothelial cell culture.

Authors:  E F Smeets; E J von Asmuth; C J van der Linden; J F Leeuwenberg; W A Buurman
Journal:  Biotech Histochem       Date:  1992-07       Impact factor: 1.718

9.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

10.  A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.

Authors:  Z P Yang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more
  25 in total

1.  Reduced transendothelial migration of monocytes infected by Coxiella burnetii.

Authors:  J Dellacasagrande; P A Moulin; C Guilianelli; C Capo; D Raoult; G E Grau; J L Mege
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.

Authors:  Pasquale Esposito; Carmine Tinelli; Carmelo Libetta; Elisa Gabanti; Teresa Rampino; Antonio Dal Canton
Journal:  Cell Stress Chaperones       Date:  2010-10-05       Impact factor: 3.667

5.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

6.  Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection.

Authors:  Li Jun Zhang; Li Jun Zhang; Wei Quan; Bei Bei Wang; Bing Ling Shen; Teng Teng Zhang; Yi Kang
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

7.  Chlamydia pneumoniae GroEL1 protein is cell surface associated and required for infection of HEp-2 cells.

Authors:  Frederik N Wuppermann; Katja Mölleken; Marion Julien; Christian A Jantos; Johannes H Hegemann
Journal:  J Bacteriol       Date:  2008-02-29       Impact factor: 3.490

Review 8.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.

Authors:  Christopher L Grigsby; Kam W Leong
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

Review 9.  Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.

Authors:  Satoru Hirono; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

10.  Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.

Authors:  Shuang Chen; Rosalinda Sorrentino; Kenichi Shimada; Yonca Bulut; Terence M Doherty; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.